The U.S. Food and Drug Administration has approved odevixibat (Bylvay; Albireo Pharma, Inc) for the treatment of pruritus in all subtypes of progressive familial intrahepatic cholestasis (PFIC), according to a press release. Odevixibat...

The Lupus Foundation of America awarded 6 grants to young scientists involved in lupus research, according to a press release. The Gina M. Finzi Memorial Student Summer Fellowship Program aims to mentor and...

Although progress in survival trends for brain cancer, lung cancer, acute myeloid leukemia, and colon and rectum cancers in adolescents has been made over the last 40 years, new research shows that minimal...

Mycophenolate mofetil (MMF) appears safe and effective as a second-line immunosuppressive agent in patients with thyroid eye disease (TED), according to a study. In this retrospective cohort study, 20 patients with active moderate-severe to sight-threatening...

A specific donor-to-recipient size-matching strategy based on a predicted total lung capacity (D-R pTLC) ratio of 0.8≥ <1.2 improved outcomes after double lung transplant (DLTX) in patients with restrictive lung disease, according to...